Related Experiment Video
Updated: Feb 7, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Discharge Hemoglobin Level and 30-Day Readmission Rates After Coronary Artery Bypass Surgery
Brian C Cho1, Vincent M DeMario1, Michael C Grant1
1From the Department of Anesthesiology/Critical Care Medicine.
Insights
Lower discharge hemoglobin levels after coronary artery bypass grafting (CABG) did not increase 30-day readmission rates. However, severe anemia (hemoglobin <8 g/dL) at discharge may be linked to higher readmission risks.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Anemia Management
Background:
- Restrictive transfusion strategies are reducing blood use in cardiac surgery.
- The impact of lower discharge hemoglobin (Hb) levels on readmission rates after coronary artery bypass grafting (CABG) requires further investigation.
Purpose of the Study:
- To compare 30-day readmission rates in patients undergoing CABG with higher versus lower discharge Hb levels.
- To evaluate the association between specific anemia severity cohorts and 30-day readmission rates.
Main Methods:
- Retrospective evaluation of 1552 isolated CABG patients.
- Comparison of "high" (above mean) and "low" (below mean) discharge Hb cohorts (mean discharge Hb: 9.4 g/dL).
- Analysis of 4 anemia cohorts (no anemia, mild, moderate, severe) and risk adjustment for multiple factors.
Main Results:
- No significant difference in 30-day readmission rates between "high" (10.2%) and "low" (12.0%) Hb cohorts (P = .25).
- Patients with discharge Hb <8 g/dL showed a higher readmission incidence (17.1%) compared to those with Hb ≥8 g/dL (10.6%) (P = .036).
- Discharge Hb <8 g/dL was a significant predictor of readmission (OR, 1.77; P = .03), with volume overload as the primary readmission cause.
Conclusions:
- Discharge Hb levels below the institutional mean for CABG patients are not associated with increased 30-day readmission.
- A potential increased readmission risk is suggested for the small subgroup of patients discharged with Hb <8 g/dL.
- Further controlled studies are needed to confirm the association between very low discharge Hb and readmission risk.
Background:
Restrictive transfusion strategies supported by large randomized trials are resulting in decreased blood utilization in cardiac surgery. What remains to be determined, however, is the impact of lower discharge hemoglobin (Hb) levels on readmission rates. We assessed patients with higher versus lower Hb levels on discharge to compare 30-day readmission rates after coronary artery bypass grafting (CABG).
Methods:
We retrospectively evaluated 1552 patients undergoing isolated CABG at our institution from January 2013 to May 2016. We evaluated 2 Hb cohorts: "high" (above) and "low" (below) the mean discharge Hb level of 9.4 g/dL, comparing patient characteristics, blood utilization, and clinical outcomes including 30-day readmission rates. We further evaluated the effects of the lowest (<8 g/dL) discharge Hb levels on 30-day readmission rates by dividing the patients into 4 anemia cohorts based on discharge Hb levels: "no anemia" (>12 g/dL), "mild anemia" (10-11.9 g/dL), "moderate anemia" (8-9.9 g/dL), and "severe anemia" (<8 g/dL). Risk adjustment accounted for age, sex, Charlson comorbidity index, preoperative comorbidities, revision sternotomy, and patient blood management program implementation.
Results:
The "high" and "low" groups had similar patient characteristics except for Hb levels (mean discharge Hb was 10.4 ± 0.9 vs 8.5 ± 0.6 g/dL, respectively). Notably, no evidence for a difference in 30-day readmission rates was noted between the "high" (76/746; 10.2%) and "low" (97/806; 12.0%) (P = .25) Hb cohorts. The 4 anemia cohorts had differences in age, revision sternotomy incidence, Hb levels, certain patient comorbidities, and time to readmission. On multivariable analysis, the risk-adjusted odds of readmission in the "low" Hb cohort (odds ratio, 1.16; 95% confidence interval, 0.84-1.61; P = .36) was not significant compared to the "high" Hb cohort. Compared to patients with discharge Hb ≥8 g/dL, patients with Hb <8 g/dL had a higher incidence of readmission (22/129; 17.1% vs 151/1423; 10.6%; P = .036). On multivariable analysis, Hb <8 g/dL on discharge was predictive of readmission (odds ratio, 1.77; 95% confidence interval, 1.05-2.88; P = .03). The most common reason for readmission was volume overload, followed by infection and arrhythmias.
Conclusions:
A discharge Hb level below the institution mean for CABG patients does not provide evidence for an association with an increased 30-day readmission rate. In the small number of patients discharged with Hb <8 g/dL, there is a suggestion of increased risk for readmission and larger more controlled studies are needed to verify or refute this finding.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures

